K-numberK260314
Device nameAncora-SB
ApplicantAspero Medical, Inc.
Product codeFDA
Device classClass II
Decision dateMay 1, 2026
DecisionSubstantially Equivalent
Regulation876.1500
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Ancora-SB is a single-use balloon overtube accessory that slides over a standard endoscope (9.0–9.4 mm diameter) to facilitate small intestine positioning and visualization. It features dual lumens: a major lumen with hydrophilic coating for endoscope insertion and a minor lumen for balloon inflation. When inflated, the textured distal balloon stabilizes endoscope position or facilitates advancement through a technique called plication, enabling diagnostic and therapeutic endoscopic procedures.

Technological characteristics

The modified device changes the hydrophilic coating formulation from PVP-based to PEG-based to improve friction performance in challenging use cases, and replaces the radiopaque marker material from platinum to barium sulfate-impregnated silicone. All other specifications remain identical: 38 mm balloon diameter, 43 mL injection volume, 132 cm working length, dual-lumen silicone construction, and identical proximal connections and balloon design.

Test standards cited

Biocompatibility evaluated per ISO 10993-1:2018 and associated FDA guidance. Bench testing included friction evaluation under challenging use conditions, end cap bond strength verification, and radiopacity assessment. A revised proprietary test method was implemented to support the coating formulation change.

Substantial equivalence argument

Substantial equivalence is supported by identical indications for use, operating principle, and design intent compared to the originally cleared Ancora-SB (K231323). The material changes are limited in scope and targeted to address performance (friction), not safety or effectiveness. Testing demonstrates the new PEG-based coating maintains acceptable friction, the modified end cap maintains structural integrity, and the new radiopaque material functions adequately—none of these changes raise new safety or effectiveness concerns relative to the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →